Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
J Immunol
    November 2024
  1. TONG X, Deng Y, Cizmeci D, Fontana L, et al
    Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
    J Immunol. 2024 Nov 17:ji2200956. doi: 10.4049/jimmunol.2200956.
    >> Share

    June 2024
  2. HE Z, Li W, Zhang M, Huang M, et al
    RNF216 Inhibits the Replication of H5N1 Avian Influenza Virus and Regulates the RIG-I Signaling Pathway in Ducks.
    J Immunol. 2024 Jun 3:ji2300540. doi: 10.4049/jimmunol.2300540.
    >> Share

  3. LEIGHTON PA, Ching K, Reynolds K, Vuong CN, et al
    Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies.
    J Immunol. 2024;212:1744-1753.
    >> Share

  4. LEE MJ, de Los Rios Kobara I, Barnard TR, Vales Torres X, et al
    NK Cell-Monocyte Cross-talk Underlies NK Cell Activation in Severe COVID-19.
    J Immunol. 2024;212:1693-1705.
    >> Share

    May 2024
  5. BOUCHER J, Gilbert C, Bose S, Tessier PA, et al
    S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.
    J Immunol. 2024;212:1523-1529.
    >> Share

  6. SAITO S, Bozorgmehr N, Sligl W, Osman M, et al
    The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2-Infected Individuals with Severe Disease.
    J Immunol. 2024;212:1540-1552.
    >> Share

    April 2024
  7. BUDYLOWSKI P, Chau SLL, Banerjee A, Guvenc F, et al
    A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera.
    J Immunol. 2024 Apr 29:ji2300320. doi: 10.4049/jimmunol.2300320.
    >> Share

  8. KUNDURA L, Cezar R, Ballongue E, Andre S, et al
    Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency.
    J Immunol. 2024;212:1105-1112.
    >> Share

  9. ABE K, Beer JC, Nguyen T, Ariyapala IS, et al
    Cross-Platform Comparison of Highly Sensitive Immunoassays for Inflammatory Markers in a COVID-19 Cohort.
    J Immunol. 2024;212:1244-1253.
    >> Share

    March 2024
  10. LI W, Lin Y, Wang X, Yang H, et al
    Chicken UFL1 Restricts Avian Influenza Virus Replication by Disrupting the Viral Polymerase Complex and Facilitating Type I IFN Production.
    J Immunol. 2024 Mar 13:ji2300613. doi: 10.4049/jimmunol.2300613.
    >> Share

  11. READ KA, Amici SA, Farsi S, Cutcliffe M, et al
    PRMT5 Promotes T follicular helper Cell Differentiation and Germinal Center Responses during Influenza Virus Infection.
    J Immunol. 2024 Mar 4:ji2300270. doi: 10.4049/jimmunol.2300270.
    >> Share

  12. AL-AHMAD A
    Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2024;212:753.
    >> Share

  13. MAINO A, Amen A, Plumas J, Bouquet L, et al
    Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells.
    J Immunol. 2024;212:825-833.
    >> Share

    February 2024
  14. TANDON P, Abrams ND, Avula LR, Carrick DM, et al
    Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report.
    J Immunol. 2024;212:505-512.
    >> Share

  15. BRADSHAW CM, Georgieva T, Tankersley TN, Taylor-Doyle T, et al
    Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
    J Immunol. 2024;212:523-528.
    >> Share

  16. DHANUSHKODI NR, Prakash S, Quadiri A, Zayou L, et al
    Antiviral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models.
    J Immunol. 2024;212:576-585.
    >> Share

  17. KAMMANN T, Gorin JB, Parrot T, Gao Y, et al
    Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies.
    J Immunol. 2024;212:389-396.
    >> Share

    November 2023
  18. LOBBY JL, Danzy S, Holmes KE, Lowen AC, et al
    Both Humoral and Cellular Immunity Limit the Ability of Live Attenuated Influenza Vaccines to Promote T Cell Responses.
    J Immunol. 2023 Nov 20:ji2300343. doi: 10.4049/jimmunol.2300343.
    >> Share

  19. EVANS JP, Liu SL
    Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies.
    J Immunol. 2023;211:1459-1467.
    >> Share

    October 2023
  20. MA W, Loving CL, Driver JP
    From Snoot to Tail: A Brief Review of Influenza Virus Infection and Immunity in Pigs.
    J Immunol. 2023;211:1187-1194.
    >> Share

  21. DIAZ FE, McGill JL
    Modeling Human Respiratory Syncytial Virus (RSV) Infection: Recent Contributions and Future Directions Using the Calf Model of Bovine RSV Disease.
    J Immunol. 2023;211:1180-1186.
    >> Share

    Infection Dynamics, Pathogenesis, and Immunity to SARS-CoV-2 in Naturally Susceptible Animal Species.
    J Immunol. 2023;211:1195-1201.
    >> Share

  23. ROSENBERG-HASSON Y, Holmes TH, Diray-Arce J, Chen J, et al
    Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients.
    J Immunol. 2023;211:1224-1231.
    >> Share

    September 2023
  24. LUCKE J, Heinrich F, Malsy J, Meins N, et al
    Intestinal IL-1beta Plays a Role in Protecting against SARS-CoV-2 Infection.
    J Immunol. 2023;211:1052-1061.
    >> Share

    August 2023
  25. SANDBERG JK, Leeansyah E, Eller MA, Shacklett BL, et al
    The Emerging Role of MAIT Cell Responses in Viral Infections.
    J Immunol. 2023;211:511-517.
    >> Share

  26. CAO L, Hui X, Xu T, Mao H, et al
    The RNA-Splicing Ligase RTCB Promotes Influenza A Virus Replication by Suppressing Innate Immunity via Interaction with RNA Helicase DDX1.
    J Immunol. 2023 Aug 9:ji2200799. doi: 10.4049/jimmunol.2200799.
    >> Share

    July 2023
  27. YU H, Worrall LJ, Berger T, Petric M, et al
    Identification of an optimized Receptor-Binding Domain Subunit Vaccine against SARS-CoV-2.
    J Immunol. 2023 Jul 26:ji2300282. doi: 10.4049/jimmunol.2300282.
    >> Share

  28. LAW JC, Watts TH
    Considerations for Choosing T Cell Assays during a Pandemic.
    J Immunol. 2023;211:169-174.
    >> Share

  29. PONDE NO, Shoger KE, Khatun MS, Sarkar MK, et al
    SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor.
    J Immunol. 2023;211:252-260.
    >> Share

    June 2023
  30. CHEUNG MW, Dayam RM, Shapiro JR, Law JC, et al
    Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
    J Immunol. 2023 Jun 16:ji2300190. doi: 10.4049/jimmunol.2300190.
    >> Share

  31. MAMBELLI F, Marinho FV, Andrade JM, de Araujo ACVSC, et al
    Recombinant Bacillus Calmette-Guerin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.
    J Immunol. 2023;210:1925-1937.
    >> Share

  32. PAIDI RK, Jana M, Raha S, Mishra RK, et al
    Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19.
    J Immunol. 2023;210:1938-1949.
    >> Share

  33. NAM H, Koh JY, Jung JH, Jeong H, et al
    Distinctive Dynamics and Functions of the CD4+CD25+FOXP3+ Regulatory T Cell Population in Patients with Severe and Mild COVID-19.
    J Immunol. 2023;210:1687-1699.
    >> Share

    May 2023
  34. PHAN JM, Layton ED, Yu KKQ, Aguilar MS, et al
    Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2.
    J Immunol. 2023;210:1236-1246.
    >> Share

    March 2023
  35. FINN CM, Dhume K, Prokop E, Strutt TM, et al
    STAT1 Controls the Functionality of Influenza-Primed CD4 T Cells but Therapeutic STAT4 Engagement Maximizes Their Antiviral Impact.
    J Immunol. 2023 Mar 24:ji2200407. doi: 10.4049/jimmunol.2200407.
    >> Share

  36. HEMANN EA, Knoll ML, Wilkins CR, Subra C, et al
    A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
    J Immunol. 2023 Mar 20:ji2300026. doi: 10.4049/jimmunol.2300026.
    >> Share

  37. VAN DE WALL S, Crooks S, Varga SM, Badovinac VP, et al
    Cutting Edge: Influenza-Induced CD11alo Airway CD103+ Tissue Resident Memory T Cells Exhibit Compromised IFN-gamma Production after In Vivo TCR Stimulation.
    J Immunol. 2023 Mar 13:ji2200931. doi: 10.4049/jimmunol.2200931.
    >> Share

  38. ZHAO Y, Xiao W, Wu Y, Fan W, et al
    Parallel T Cell Immunogenic Regions in Influenza B and A Viruses with Distinct Nuclear Export Signal Functions: The Balance between Viral Life Cycle and Immune Escape.
    J Immunol. 2023 Mar 10:ji2200243. doi: 10.4049/jimmunol.2200243.
    >> Share

  39. SHAMSELDIN MM, Kenney A, Zani A, Evans JP, et al
    Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
    J Immunol. 2023 Mar 6:ji2200297. doi: 10.4049/jimmunol.2200297.
    >> Share

    February 2023
  40. VON RICHTHOFEN HJ, Westerlaken GHA, Gollnast D, Besteman S, et al
    Soluble Signal Inhibitory Receptor on Leukocytes-1 Is Released from Activated Neutrophils by Proteinase 3 Cleavage.
    J Immunol. 2023;210:389-397.
    >> Share

  41. QUINN M, Parra-Rodriguez L, Alsoussi WB, Ayres C, et al
    Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination.
    J Immunol. 2023 Feb 13:ji2200920. doi: 10.4049/jimmunol.2200920.
    >> Share

  42. SEREZANI CH, Divangahi M, Peters-Golden M
    Leukotrienes in Innate Immunity: Still Underappreciated after All These Years?
    J Immunol. 2023;210:221-227.
    >> Share

    January 2023
  43. NG T, Flores-Malavet V, Mansoor MAM, Arvelo AC, et al
    Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against Influenza.
    J Immunol. 2023 Jan 16:ji2200393. doi: 10.4049/jimmunol.2200393.
    >> Share

    December 2022
  44. MISE-OMATA S, Ikeda M, Takeshita M, Uwamino Y, et al
    Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant.
    J Immunol. 2022;209:2104-2113.
    >> Share

    November 2022
  45. ZHENG MZM, Fritzlar S, Wang Z, Tan TK, et al
    Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8+ T Cells in the Face of Pre-Existing Humoral Immunity.
    J Immunol. 2022;209:1832-1836.
    >> Share

  46. BREZNIK JA, Huynh A, Zhang A, Bilaver L, et al
    Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.
    J Immunol. 2022;209:1892-1905.
    >> Share

  47. LOBBY JL, Uddback I, Scharer CD, Mi T, et al
    Persistent Antigen Harbored by Alveolar Macrophages Enhances the Maintenance of Lung-Resident Memory CD8(+) T Cells.
    J Immunol. 2022;209:1778-1787.
    >> Share

    October 2022
  48. MILLER D, Garcia-Flores V, Romero R, Galaz J, et al
    Single-Cell Immunobiology of the Maternal-Fetal Interface.
    J Immunol. 2022;209:1450-1464.
    >> Share

  49. SHOOK LL, Fourman LT, Edlow AG
    Immune Responses to SARS-CoV-2 in Pregnancy: Implications for the Health of the Next Generation.
    J Immunol. 2022;209:1465-1473.
    >> Share

  50. ADHIKARI A, Abayasingam A, Rodrigo C, Agapiou D, et al
    Longitudinal Characterization of Phagocytic and Neutralization Functions of Anti-Spike Antibodies in Plasma of Patients after Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Immunol. 2022;209:1499-1512.
    >> Share

  51. ZHENG MZM, Fritzlar S, Wang Z, Tan TK, et al
    Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8(+) T Cells in the Face of Pre-Existing Humoral Immunity.
    J Immunol. 2022 Oct 5. pii: jimmunol.2200577. doi: 10.4049/jimmunol.2200577.
    >> Share

  52. PENG X, Kim J, Gupta G, Agaronyan K, et al
    Coronavirus Lung Infection Impairs Host Immunity against Secondary Bacterial Infection by Promoting Lysosomal Dysfunction.
    J Immunol. 2022;209:1314-1322.
    >> Share

  53. SCHWARZ B, Roberts LM, Bohrnsen E, Jessop F, et al
    Contribution of Lipid Mediators in Divergent Outcomes following Acute Bacterial and Viral Lung Infections in the Obese Host.
    J Immunol. 2022;209:1323-1334.
    >> Share

    September 2022
  54. BREZNIK JA, Huynh A, Zhang A, Bilaver L, et al
    Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.
    J Immunol. 2022 Sep 28. pii: jimmunol.2200369. doi: 10.4049/jimmunol.2200369.
    >> Share

    August 2022
  55. LUAN Y, Yuan Q, Wang Q, Compton S, et al
    Pazopanib Is a Potential Treatment for Coronavirus-Induced Lung Injuries.
    J Immunol. 2022;209:723-730.
    >> Share

  56. CAMPANA S, De Pasquale C, Sidoti Migliore G, Pezzino G, et al
    Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients.
    J Immunol. 2022;209:655-659.
    >> Share

  57. DAI M, Sun H, Zhao L, Wu Q, et al
    Duck CD8(+) T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus Infection In Vivo and In Vitro.
    J Immunol. 2022 Aug 8. pii: jimmunol.2101147. doi: 10.4049/jimmunol.2101147.
    >> Share

  58. CIPOLLA EM, Yue M, Nickolich KL, Huckestein BR, et al
    Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial Infection.
    J Immunol. 2022 Aug 1. pii: jimmunol.2200261. doi: 10.4049/jimmunol.2200261.
    >> Share

    July 2022
  59. PEREZ MM, Pimentel VE, Fuzo CA, da Silva-Neto PV, et al
    Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity.
    J Immunol. 2022;209:250-261.
    >> Share

  60. PALANI S, Bansal S, Verma AK, Bauer C, et al
    Type I IFN Signaling Is Essential for Preventing IFN-gamma Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection.
    J Immunol. 2022;209:128-135.
    >> Share

    June 2022
  61. CUSIMANO GM, Gary EN, Bell MR, Warner BM, et al
    Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1.
    J Immunol. 2022 Jun 24. pii: jimmunol.2200056. doi: 10.4049/jimmunol.2200056.
    >> Share

  62. SEBINA I, Rashid RB, Sikder MAA, Rahman MM, et al
    IFN-lambda Diminishes the Severity of Viral Bronchiolitis in Neonatal Mice by Limiting NADPH Oxidase-Induced PAD4-Independent NETosis.
    J Immunol. 2022;208:2806-2816.
    >> Share

  63. CHEN Y, Ye Z, Zhang Y, Xie W, et al
    A Deep Learning Model for Accurate Diagnosis of Infection Using Antibody Repertoires.
    J Immunol. 2022;208:2675-2685.
    >> Share

  64. NAGASHIMA K, Dzimianski JV, Han J, Abbadi N, et al
    The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.
    J Immunol. 2022 Jun 13. pii: jimmunol.2101171. doi: 10.4049/jimmunol.2101171.
    >> Share

  65. LOUIE AY, Tingling J, Dray E, Hussain J, et al
    Dietary Cholesterol Causes Inflammatory Imbalance and Exacerbates Morbidity in Mice Infected with Influenza A Virus.
    J Immunol. 2022;208:2523-2539.
    >> Share

  66. JERGOVIC M, Coplen CP, Uhrlaub JL, Beitel SC, et al
    Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
    J Immunol. 2022;208:2461-2465.
    >> Share

    May 2022
  67. TAN HX, Wragg KM, Kelly HG, Esterbauer R, et al
    Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil.
    J Immunol. 2022;208:2267-2271.
    >> Share

  68. LI H, Zhao M, Zhang H, Quan C, et al
    Pneumonia Severity and Phase Linked to Virus-Specific T Cell Responses with Distinct Immune Checkpoints during pH1N1 Infection.
    J Immunol. 2022;208:2154-2162.
    >> Share

    April 2022
  69. HOUSER CL, Lawrence BP
    The Aryl Hydrocarbon Receptor Modulates T Follicular Helper Cell Responses to Influenza Virus Infection in Mice.
    J Immunol. 2022 Apr 20. pii: jimmunol.2100936. doi: 10.4049/jimmunol.2100936.
    >> Share

  70. GOMEZ-LOPEZ N, Romero R, Tao L, Gershater M, et al
    Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women.
    J Immunol. 2022;208:1857-1872.
    >> Share

  71. YANG X, Rutkovsky AC, Zhou J, Zhong Y, et al
    Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.
    J Immunol. 2022;208:1968-1977.
    >> Share

  72. ZHAI B, Clarke K, Bauer DL, Moehling Geffel KK, et al
    SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients.
    J Immunol. 2022;208:1711-1718.
    >> Share

    March 2022
  73. JEONG S, Jeon M, Lee H, Kim SY, et al
    IFITM3 Is Upregulated Characteristically in IL-15-Mediated Bystander-Activated CD8(+) T Cells during Influenza Infection.
    J Immunol. 2022 Mar 28. pii: jimmunol.2100629. doi: 10.4049/jimmunol.2100629.
    >> Share

  74. DHUME K, Finn CM, Devarajan P, Singh A, et al
    Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza.
    J Immunol. 2022 Mar 25. pii: jimmunol.2100801. doi: 10.4049/jimmunol.2100801.
    >> Share

  75. COSTANTINI VP, Nguyen K, Lyski Z, Novosad S, et al
    Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG.
    J Immunol. 2022;208:1500-1508.
    >> Share

  76. HAZAN G, Eubanks A, Gierasch C, Atkinson J, et al
    Age-Dependent Reduction in Asthmatic Pathology through Reprogramming of Postviral Inflammatory Responses.
    J Immunol. 2022;208:1467-1482.
    >> Share

  77. GAO X, Zhu B, Wu Y, Li C, et al
    TFAM-Dependent Mitochondrial Metabolism Is Required for Alveolar Macrophage Maintenance and Homeostasis.
    J Immunol. 2022;208:1456-1466.
    >> Share

  78. YUZEFPOLSKIY Y, Morawski P, Fahning M, Speake C, et al
    Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
    J Immunol. 2022 Mar 14. pii: jimmunol.2101142. doi: 10.4049/jimmunol.2101142.
    >> Share

    February 2022
  79. MEYER-ARNDT L, Schwarz T, Loyal L, Henze L, et al
    Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4(+) T Cells following BNT162b2 Vaccination in the Elderly.
    J Immunol. 2022 Feb 4. pii: jimmunol.2100990. doi: 10.4049/jimmunol.2100990.
    >> Share

  80. NICOLI F, Cabral-Piccin MP, Papagno L, Gallerani E, et al
    Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8(+) T Cells in Elderly Humans.
    J Immunol. 2022;208:562-570.
    >> Share

  81. SUI C, Xiao T, Zhang S, Zeng H, et al
    SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy.
    J Immunol. 2022;208:753-761.
    >> Share

  82. DUTT TS, LaVergne SM, Webb TL, Baxter BA, et al
    Comprehensive Immune Profiling Reveals CD56(+) Monocytes and CD31(+) Endothelial Cells Are Increased in Severe COVID-19 Disease.
    J Immunol. 2022;208:685-696.
    >> Share

    January 2022
  83. KOMISSAROV AA, Dolzhikova IV, Efimov GA, Logunov DY, et al
    Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.
    J Immunol. 2022 Jan 31. pii: jimmunol.2101052. doi: 10.4049/jimmunol.2101052.
    >> Share

  84. TU MK, Chiang SH, Bender RA, Wong DTW, et al
    The Kinetics of COVID-19 Vaccine Response in a Community-Vaccinated Population.
    J Immunol. 2022 Jan 17. pii: jimmunol.2100919. doi: 10.4049/jimmunol.2100919.
    >> Share

  85. LAW JC, Girard M, Chao GYC, Ward LA, et al
    Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset.
    J Immunol. 2022;208:429-443.
    >> Share

  86. HOPE JL, Zhao M, Stairiker CJ, Kiernan CH, et al
    MicroRNA-139 Expression Is Dispensable for the Generation of Influenza-Specific CD8(+) T Cell Responses.
    J Immunol. 2022 Jan 12. pii: jimmunol.2000621. doi: 10.4049/jimmunol.2000621.
    >> Share

  87. HARTWIG SM, Miller AM, Varga SM
    Respiratory Syncytial Virus Provides Protection against a Subsequent Influenza A Virus Infection.
    J Immunol. 2022 Jan 12. pii: jimmunol.2000751. doi: 10.4049/jimmunol.2000751.
    >> Share

  88. WU B, Ramaiah A, Garcia G Jr, Hasiakos S, et al
    ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
    J Immunol. 2022;208:74-84.
    >> Share

    November 2021
  89. LIU Y, Budylowski P, Dong S, Li Z, et al
    SARS-CoV-2-Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals.
    J Immunol. 2021;207:2581-2588.
    >> Share

  90. HUSSAIN SA, Rohlfing M, Resiliac J, Santoro J, et al
    Atopic Neutrophils Prevent Postviral Airway Disease.
    J Immunol. 2021;207:2589-2597.
    >> Share

  91. JEEWANDARA C, Guruge D, Pushpakumara PD, Kamaladasa A, et al
    Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
    J Immunol. 2021 Nov 8. pii: jimmunol.2100762. doi: 10.4049/jimmunol.2100762.
    >> Share

  92. GAJANAYAKA N, Dong SXM, Ali H, Iqbal S, et al
    TLR-4 Agonist Induces IFN-gamma Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K Pathway.
    J Immunol. 2021;207:2310-2324.
    >> Share

    October 2021
  93. WANG Y, Karki R, Zheng M, Kancharana B, et al
    Cutting Edge: Caspase-8 Is a Linchpin in Caspase-3 and Gasdermin D Activation to Control Cell Death, Cytokine Release, and Host Defense during Influenza A Virus Infection.
    J Immunol. 2021 Oct 18. pii: jimmunol.2100757. doi: 10.4049/jimmunol.2100757.
    >> Share

  94. BANSAL S, Perincheri S, Fleming T, Poulson C, et al
    Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    J Immunol. 2021 Oct 15. pii: jimmunol.2100637. doi: 10.4049/jimmunol.2100637.
    >> Share

  95. PAIDI RK, Jana M, Mishra RK, Dutta D, et al
    Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    J Immunol. 2021 Oct 13. pii: jimmunol.2100144. doi: 10.4049/jimmunol.2100144.
    >> Share

  96. YANG Q, Wen Y, Qi F, Gao X, et al
    Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.
    J Immunol. 2021;207:1848-1856.
    >> Share

  97. SCOTT J, Ruchaud-Sparagano MH, Musgrave K, Roy AI, et al
    Phosphoinositide 3-Kinase delta Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of Infection.
    J Immunol. 2021;207:1776-1784.
    >> Share

    September 2021
  98. ALVES I, Vicente MM, Gaifem J, Fernandes A, et al
    SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.
    J Immunol. 2021;207:1591-1598.
    >> Share

  99. Top Reads.
    J Immunol. 2021;207:1495.
    >> Share

  100. MA T, Ryu H, McGregor M, Babcock B, et al
    Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence.
    J Immunol. 2021;207:1344-1356.
    >> Share

    August 2021
  101. SHAHBAZ S, Xu L, Sligl W, Osman M, et al
    The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.
    J Immunol. 2021;207:1099-1111.
    >> Share

  102. OCHSNER SP, Li W, Rajendrakumar AM, Palaniyandi S, et al
    FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100297. doi: 10.4049/jimmunol.2100297.
    >> Share

  103. VERMA AK, Bauer C, Palani S, Metzger DW, et al
    IFN-gamma Drives TNF-alpha Hyperproduction and Lethal Lung Inflammation during Antibiotic Treatment of Postinfluenza Staphylococcus aureus Pneumonia.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100328. doi: 10.4049/jimmunol.2100328.
    >> Share

  104. REYNOLDS D, Vazquez Guillamet C, Day A, Borcherding N, et al
    Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
    J Immunol. 2021 Aug 4. pii: jimmunol.2100294. doi: 10.4049/jimmunol.2100294.
    >> Share

  105. BAYARRI-OLMOS R, Idorn M, Rosbjerg A, Perez-Alos L, et al
    SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
    J Immunol. 2021;207:878-887.
    >> Share

    July 2021
  106. AVENDANO-ORTIZ J, Lozano-Rodriguez R, Martin-Quiros A, Maroun-Eid C, et al
    SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.
    J Immunol. 2021;207:162-174.
    >> Share

  107. Top Reads.
    J Immunol. 2021;207:1-2.
    >> Share

    June 2021
  108. MATCHETT WE, Joag V, Stolley JM, Shepherd FK, et al
    Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.
    J Immunol. 2021 Jun 30. pii: jimmunol.2100421. doi: 10.4049/jimmunol.2100421.
    >> Share

  109. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Correction: Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2021 Jun 18. pii: jimmunol.2100261. doi: 10.4049/jimmunol.2100261.
    >> Share

  110. LIU X, Zhao J, Wang H, Wang W, et al
    Metabolic Defects of Peripheral T Cells in COVID-19 Patients.
    J Immunol. 2021;206:2900-2908.
    >> Share

  111. Top Reads.
    J Immunol. 2021;206:2773-2774.
    >> Share

  112. HOEHN KB, Ramanathan P, Unterman A, Sumida TS, et al
    Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19.
    J Immunol. 2021;206:2785-2790.
    >> Share

  113. SANDOR AM, Sturdivant MS, Ting JPY
    Influenza Virus and SARS-CoV-2 Vaccines.
    J Immunol. 2021;206:2509-2520.
    >> Share

  114. JAHRSDORFER B, Gross R, Seidel A, Wettstein L, et al
    Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.
    J Immunol. 2021;206:2614-2622.
    >> Share

  115. MANTUS G, Nyhoff LE, Kauffman RC, Edara VV, et al
    Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain.
    J Immunol. 2021;206:2605-2613.
    >> Share

    May 2021
  116. OCCHIGROSSI L, Rossin F, D'Eletto M, Farrace MG, et al
    Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis.
    J Immunol. 2021;206:2420-2429.
    >> Share

  117. FUJIGAKI H, Inaba M, Osawa M, Moriyama S, et al
    Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients.
    J Immunol. 2021;206:2393-2401.
    >> Share

  118. YAN Q, Li P, Ye X, Huang X, et al
    Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
    J Immunol. 2021;206:2146-2159.
    >> Share

    April 2021
  119. CROOKE PS 3RD, Tossberg JT, Porter KP, Aune TM, et al
    Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
    J Immunol. 2021;206:1691-1696.
    >> Share

  120. HUANG W, Li M, Luo G, Wu X, et al
    The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression.
    J Immunol. 2021;206:1597-1608.
    >> Share

  121. RUPP J, Dreo B, Gutl K, Fessler J, et al
    T Cell Phenotyping in Individuals Hospitalized with COVID-19.
    J Immunol. 2021;206:1478-1482.
    >> Share

  122. FRANZETTI M, Forastieri A, Borsa N, Pandolfo A, et al
    IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.
    J Immunol. 2021;206:1569-1575.
    >> Share

  123. PRICE MJ, Scharer CD, Kania AK, Randall TD, et al
    Conserved Epigenetic Programming and Enhanced Heme Metabolism Drive Memory B Cell Reactivation.
    J Immunol. 2021;206:1493-1504.
    >> Share

    March 2021
  124. MALINCZAK CA, Parolia A, Fonseca W, Morris S, et al
    TSLP-Driven Chromatin Remodeling and Trained Systemic Immunity after Neonatal Respiratory Viral Infection.
    J Immunol. 2021;206:1315-1328.
    >> Share

    February 2021
  125. TIAN J, Zhang M, Jin M, Zhang F, et al
    Repurposed Tocilizumab in Patients with Severe COVID-19.
    J Immunol. 2021;206:599-606.
    >> Share

  126. ZELBA H, Worbs D, Harter J, Pieper N, et al
    A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4(+) and CD8(+) T Cells in COVID-19 Patients.
    J Immunol. 2021;206:580-587.
    >> Share

    January 2021
  127. SCHWARZ B, Sharma L, Roberts L, Peng X, et al
    Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
    J Immunol. 2021;206:329-334.
    >> Share

  128. JOAG V, Wijeyesinghe S, Stolley JM, Quarnstrom CF, et al
    Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.
    J Immunol. 2021 Jan 13. pii: jimmunol.2001400. doi: 10.4049/jimmunol.2001400.
    >> Share

  129. HANSEN CB, Jarlhelt I, Perez-Alos L, Hummelshoj Landsy L, et al
    SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
    J Immunol. 2021;206:109-117.
    >> Share

    December 2020
  130. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2020 Dec 16. pii: jimmunol.2001086. doi: 10.4049/jimmunol.2001086.
    >> Share

  131. VOGELZANG EH, Loeff FC, Derksen NIL, Kruithof S, et al
    Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.
    J Immunol. 2020;205:3491-3499.
    >> Share

  132. MARTINEZ-FLETA P, Alfranca A, Gonzalez-Alvaro I, Casasnovas JM, et al
    SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.
    J Immunol. 2020;205:3130-3140.
    >> Share

  133. KELLAR GG, Reeves SR, Barrow KA, Debley JS, et al
    Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection.
    J Immunol. 2020;205:3050-3057.
    >> Share

    November 2020
  134. LAW JC, Koh WH, Budylowski P, Lin J, et al
    Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.
    J Immunol. 2020 Nov 18. pii: jimmunol.2001067. doi: 10.4049/jimmunol.2001067.
    >> Share

  135. KALKAN YAZICI M, Koc MM, Cetin NS, Karaaslan E, et al
    Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
    J Immunol. 2020;205:2719-2725.
    >> Share

  136. NOWILL AE, de Campos-Lima PO
    Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    J Immunol. 2020;205:2566-2575.
    >> Share

  137. BAUMGARTH N, Nikolich-Zugich J, Lee FE, Bhattacharya D, et al
    Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.
    J Immunol. 2020;205:2342-2350.
    >> Share

  138. VARNAITE R, Garcia M, Glans H, Maleki KT, et al
    Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    J Immunol. 2020;205:2437-2446.
    >> Share

    October 2020
  139. ELAHI S
    Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy.
    J Immunol. 2020;205:1990-1997.
    >> Share

    September 2020
  140. SOKULSKY LA, Garcia-Netto K, Nguyen TH, Girkin JLN, et al
    A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation.
    J Immunol. 2020 Sep 18. pii: jimmunol.1901350. doi: 10.4049/jimmunol.1901350.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016